The relationship between serum prolactin levels and cognitive function in drug-naïve schizophrenia patients: a cross-sectional study Guoshuai LuoFengfeng BaiJie Li Psychiatry and Preclinical Psychiatric Studies - Original Article 26 January 2024 Pages: 385 - 391
Mild cognitive impairment in Huntington’s disease: challenges and outlooks Kurt A. Jellinger Neurology and Preclinical Neurological Studies - Review Article 24 January 2024 Pages: 289 - 304
Functional AGXT2 SNP rs180749 variant and depressive symptoms: Baseline data from the Aidai Cohort Study in Japan Hiroshi KumonYoshihiro MiyakeShu-ichi Ueno Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 23 January 2024 Pages: 267 - 274
Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view Jeswinder Sian-HulsmannPeter Riederer Neurology and Preclinical Neurological Studies - Original Article Open access 23 January 2024
Modulatory effect of olanzapine on neuronal nitric oxide synthase (nNOS) expression in the rat striatum Julia KistowskaArtur PałaszKinga Mordecka-Chamera Psychiatry and Preclinical Psychiatric Studies - Short communication 22 January 2024 Pages: 275 - 280
Association between autonomic dysfunction with motor and non-motor symptoms in patients with Parkinson's disease Yi QinDe-Tao MengBo-Yan Fang Neurology and Preclinical Neurological Studies - Original Article 22 January 2024 Pages: 323 - 334
The natural course of idiopathic cervical dystonia Dirk DresslerBruno KoppFereshte Adib Saberi Neurology and Preclinical Neurological Studies - Original Article Open access 20 January 2024 Pages: 245 - 252
Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson’s disease and during ageing in non-Parkinsonian subjects Bodil Fornstedt Wallin Neurology and Preclinical Neurological Studies - Original Article 18 January 2024 Pages: 213 - 228
Driving innovation in addiction treatment: role of transcranial magnetic stimulation Graziella MadeoAntonello Bonci Psychiatry and Preclinical Psychiatric Studies - Short Communication 17 January 2024 Pages: 505 - 508
Parkinson’s disease motor progression in relation to the timing of REM sleep behavior disorder presentation: an exploratory retrospective study Roberta BovenziMariangela PierantozziClaudio Liguori Neurology and Preclinical Neurological Studies - Original Article Open access 16 January 2024 Pages: 239 - 244
Current perspectives on brain circuits involved in food addiction-like behaviors Esra SenolHasan Mohammad Psychiatry and Preclinical Psychiatric Studies - Review Article 12 January 2024 Pages: 475 - 485
Morphometric alterations of the mesocorticolimbic network in Parkinson’s disease with impulse control disorders Mohammed Farhan AnsariShweta PrasadPramod Kumar Pal Neurology and Preclinical Neurological Studies - Original Article 12 January 2024 Pages: 229 - 237
The enigma of depression in corticobasal degeneration, a frequent but poorly understood co-morbidity Kurt A. Jellinger Neurology and Preclinical Neurological Studies - Review Article 12 January 2024 Pages: 195 - 202
Facial emotion recognition deficits are associated with hypomimia and related brain correlates in Parkinson’s disease Jon Rodríguez-AntigüedadSaül Martínez-HortaJaime Kulisevsky Neurology and Preclinical Neurological Studies - Original Article 11 January 2024
Psychometric properties of the Caregiver’s inventory neuropsychological diagnosis dementia (CINDD) in mild cognitive impairment and dementia Sofia CuocoCarlo BlundoMarina Picillo Neurology and Preclinical Neurological Studies - Original Article Open access 10 January 2024 Pages: 173 - 180
Sexual dysfunction in men with young onset Parkinson's disease M. SandeepShyam SundarRavi Yadav Neurology and Preclinical Neurological Studies - Original Article 10 January 2024 Pages: 149 - 155
Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson’s disease Makoto NaoiWakako MaruyamaPeter Riederer Neurology and Preclinical Neurological Studies - Review Article 09 January 2024
Old problems, new solutions: harnessing technology and innovation in Parkinson’s disease—evidence and experiences from Thailand Roongroj Bhidayasiri Neurology and Preclinical Neurological Studies - Original Article 08 January 2024
Advanced is advanced is advanced is advanced Wolfgang H. Jost Neurology and Preclinical Neurological Studies - Editorial 06 January 2024
Clinical correlates of pareidolias and color discrimination deficits in idiopathic REM sleep behavior disorder and Parkinson’s disease Seoyeon KimJi-Hyun ChoiJee-Young Lee Neurology and Preclinical Neurological Studies - Original Article 18 December 2023 Pages: 141 - 148
Motor cortex transcranial direct current stimulation improves non-motor symptoms in early-onset Parkinson’s disease: a pilot study Clara SimonettaJacopo BissaccoTommaso Schirinzi Neurology and Preclinical Neurological Studies - Original Article 17 December 2023 Pages: 189 - 193
Rewiring the future: drugs abused in adolescence may predispose to mental illness in adult life by altering dopamine axon growth Radu Gabriel AvramescuGiovanni HernandezCecilia Flores Psychiatry and Preclinical Psychiatric Studies - Review Article Open access 01 December 2023 Pages: 461 - 467
Neurogenic orthostatic hypotension in Parkinson’s disease: is there a role for locus coeruleus magnetic resonance imaging? Giovanni PalermoAlessandro GalganiFilippo Sean Giorgi Neurology and Preclinical Neurological Studies - Original Article Open access 30 November 2023 Pages: 157 - 164
Therapeutic use of medical Cannabis in neurological diseases: a clinical update Ute HiddingTina MainkaCarsten Buhmann Neurology and Preclinical Neurological Studies - Review Article Open access 28 November 2023 Pages: 117 - 126
Abstracts of the WASAD Congress 2023: an International Congress of the World Association for Stress Related and Anxiety Disorders, held on 11–13 September 2023 in Zurich, Switzerland Abstracts 23 November 2023 Pages: 1609 - 1639
Psychotherapies in opioid use disorder: toward a step-care model Amaury DurpoixJulie RollingLaurence Lalanne Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 21 November 2023 Pages: 437 - 452
Neuroscience in addiction research Rita J. ValentinoSunila G. NairNora D. Volkow Psychiatry and Preclinical Psychiatric Studies - Short Communication 10 November 2023 Pages: 453 - 459
Levodopa may modulate specific speech impairment in Parkinson's disease: an fMRI study Martina MračkováRadek MarečekIrena Rektorová Neurology and Preclinical Neurological Studies - Original Article 09 November 2023 Pages: 181 - 187
Astrocytic transcriptional and epigenetic mechanisms of drug addiction Leanne M. HoltEric J. Nestler Psychiatry and Preclinical Psychiatric Studies - Review Article 08 November 2023 Pages: 409 - 424
Should continuous dopaminergic stimulation be a standard of care in advanced Parkinson’s disease? Z. PirtošekV. LetaM. Vérin Neurology and Preclinical Neurological Studies - Review Article 06 November 2023 Pages: 1395 - 1404
Baseline prevalence and longitudinal assessment of autonomic dysfunction in early Parkinson’s disease Lanqing YangHuan GaoMin Ye Neurology and Preclinical Neurological Studies - Original Article 04 November 2023 Pages: 127 - 139
Understanding depression with amyotrophic lateral sclerosis: a short assessment of facts and perceptions Kurt A. Jellinger Neurology and Preclinical Neurological Studies - Review Article 03 November 2023 Pages: 107 - 115
The importance of choice and agency in animal models of addiction Serge H. Ahmed Psychiatry and Preclinical Psychiatric Studies - Review Article 31 October 2023 Pages: 487 - 489
Risk of Parkinson’s disease in hepatitis B and C populations: a systematic review and meta-analysis Clyve Yu Leon YaowAshley Shuen Ying HongEng-King Tan Neurology and Preclinical Neurological Studies - Review Article 29 October 2023
Constipation and pain in Parkinson’s disease: a clinical analysis Mohammad Al-WardatPiergiorgio GrilloSilvia Natoli Neurology and Preclinical Neurological Studies - Original Article Open access 28 October 2023 Pages: 165 - 172
Home initiation of apomorphine infusion: lessons from the COVID-19 pandemic and implications for current clinical practice Christopher KobyleckiLucy Partington-Smith Neurology and Preclinical Neurological Studies - Original Article Open access 23 October 2023 Pages: 1485 - 1489
The role of immune and inflammatory-related indicators in cognitive dysfunction and disease severity in patients with parkinson’s disease Xudong ZhaoLei LiWeifeng Luo Neurology and Preclinical Neurological Studies - Original Article 20 October 2023 Pages: 13 - 24
The specific NQO2 inhibitor, S29434, only marginally improves the survival of dopamine neurons in MPTP-intoxicated mice Maeva VallucciJean A. BoutinEtienne C. Hirsch Neurology and Preclinical Neurological Studies - Original Article 18 October 2023 Pages: 1 - 11
Botulinum toxin and conservative treatment strategies in people with cervical dystonia: an online survey Melani J. BoyceA. B. McCambridgeA. P. Verhagen Neurology and Preclinical Neurological Studies - Original Article Open access 13 October 2023 Pages: 43 - 51
Deep brain stimulation for psychostimulant use disorders Sarah E. Swinford-JacksonR. Christopher Pierce Psychiatry and Preclinical Psychiatric Studies - Review Article 12 October 2023 Pages: 469 - 473
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease Antonio CannavacciuoloGiulia PaparellaMatteo Bologna Neurology and Preclinical Neurological Studies - Original Article Open access 07 October 2023 Pages: 31 - 41
Autophagy markers, cognitive deficits and depressive symptoms in Parkinson’s disease Yanzhe LiHechao YangJie Li Psychiatry and Preclinical Psychiatric Studies - Original Article 06 October 2023 Pages: 73 - 81
A 12-month prospective real-life study of opicapone efficacy and tolerability in Emirati and non-White subjects with Parkinson’s disease based in United Arab Emirates Vinod MettaHuzaifa IbrahimK. Ray Chaudhuri Neurology and Preclinical Neurological Studies - Original Article Open access 05 October 2023 Pages: 25 - 30
L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin Peter RiedererReinhard Horowski Neurology and Preclinical Neurological Studies - Review Article Open access 05 October 2023 Pages: 1323 - 1335
Nicotinic regulation of microglia: potential contributions to addiction Alexa R. SoaresMarina R. Picciotto Psychiatry and Preclinical Psychiatric Studies - Review Article 01 October 2023 Pages: 425 - 435
The GlyT1-inhibitor Org 24598 facilitates the alcohol deprivation abolishing and dopamine elevating effects of bupropion + varenicline in rats Yasmin OlssonHelga LidöBo Söderpalm Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 29 September 2023 Pages: 95 - 106
Excessive psychological stress preceding the onset of idiopathic cervical dystonia Dirk DresslerBruno KoppFereshte Adib Saberi Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 29 September 2023 Pages: 53 - 57
Pharmacological modulation of HIF-1 in the treatment of neuropsychiatric disorders Diksha SharmaHeena KhanThakur Gurjeet Singh Psychiatry and Preclinical Psychiatric Studies - Review Article 22 September 2023 Pages: 1523 - 1535
Parkinson’s disease patients’ perspective on telephone visits during the COVID-19 pandemic Marta MagriçoMiguel SerôdioPaulo Bugalho Neurology and Preclinical Neurological Studies - Original Article 14 September 2023 Pages: 1547 - 1551
Correction to: Role of dopamine agonists in Parkinson's disease therapy D. WoitallaC. BuhmannD. Weise Correction 13 September 2023